EMEA-001784-PIP01-15-M02

Key facts

Active substance
Anti-respiratory syncytial virus human IgG1κ monoclonal antibody (MEDI8897)
Therapeutic area
Infectious diseases
Decision number
P/0082/2020
PIP number
EMEA-001784-PIP01-15-M02
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Prevention of lower respiratory tract disease caused by respiratory syncytial virus
Route(s) of administration
Intramuscular use
Contact for public enquiries
AstraZeneca AB

Tel. +46 855259283
E-mail: paediatrics@astrazeneca.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating